| Secondary |
| Rheumatoid Arthritis |
38.7% |
| Drug Use For Unknown Indication |
19.4% |
| Product Used For Unknown Indication |
18.3% |
| Bone Disorder |
5.4% |
| Osteoporosis Postmenopausal |
4.3% |
| Arthralgia |
3.2% |
| Pharyngitis |
2.2% |
| Arthritis |
1.1% |
| Arthropathy |
1.1% |
| Colitis |
1.1% |
| Hypertension |
1.1% |
| Myocardial Ischaemia |
1.1% |
| Pain |
1.1% |
| Psoriasis |
1.1% |
| Urinary Tract Infection |
1.1% |
|
| Renal Failure Acute |
22.2% |
| Hyperemesis Gravidarum |
18.5% |
| Pancytopenia |
18.5% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
7.4% |
| Tuberculous Pleurisy |
7.4% |
| Vasculitic Rash |
7.4% |
| Demyelinating Polyneuropathy |
3.7% |
| Developmental Delay |
3.7% |
| Fracture |
3.7% |
| Toxic Epidermal Necrolysis |
3.7% |
| White Blood Cell Count Increased |
3.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.9% |
| Rheumatoid Arthritis |
35.6% |
| Drug Use For Unknown Indication |
11.9% |
| Pain |
2.6% |
| Ankylosing Spondylitis |
1.9% |
| Hypertension |
1.8% |
| Psoriatic Arthropathy |
1.4% |
| Spondylitis |
1.2% |
| Crohn's Disease |
1.0% |
| Colitis Ulcerative |
0.9% |
| Cardiovascular Event Prophylaxis |
0.8% |
| Chronic Obstructive Pulmonary Disease |
0.8% |
| Polyarthritis |
0.6% |
| Analgesic Therapy |
0.4% |
| Anxiety |
0.4% |
| Blood Pressure |
0.4% |
| Coronary Artery Disease |
0.4% |
| Infection |
0.4% |
| Lower Respiratory Tract Infection |
0.4% |
| Osteoporosis |
0.4% |
|
| Sudden Death |
13.6% |
| Pneumonia |
10.0% |
| Death |
9.3% |
| Swollen Tongue |
8.6% |
| Pulmonary Embolism |
5.0% |
| Skin Ulcer |
5.0% |
| Vomiting |
5.0% |
| Colon Cancer |
4.3% |
| Non-hodgkin's Lymphoma |
4.3% |
| Cerebrovascular Accident |
3.6% |
| Drug Ineffective |
3.6% |
| Rheumatoid Arthritis |
3.6% |
| Urinary Tract Infection |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Lung Neoplasm Malignant |
2.9% |
| Myocardial Infarction |
2.9% |
| Peripheral Vascular Disorder |
2.9% |
| Pulmonary Fibrosis |
2.9% |
| Rectal Haemorrhage |
2.9% |
| Sepsis |
2.9% |
|
| Interacting |
| Rheumatoid Arthritis |
81.8% |
| Product Used For Unknown Indication |
18.2% |
|
| Renal Failure Acute |
100.0% |
|
